http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017155861-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45c06f76a5ef9e7c9c8783b6881dd738 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
| filingDate | 2017-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3257804ce518b1345893c2f6f7c4080 |
| publicationDate | 2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017155861-A1 |
| titleOfInvention | Methods of treating substance abuse related diseases or disorders |
| abstract | Compositions and methods for treating a subject for a substance-abuse related disease or disorder are disclosed. The substance-abuse related disease or disorder can be an alcohol-related, an opioid-related, a cocaine-related, an amphetamine-related, a marijuana related, hallucinogen-related, barbiturate-related, benzodiazepine-related, or VOC-related disease or disorder. The composition for treating the substance-abuse related disease or disorder can be selected from a microbiota transplant, a particular diet or diet ingredient, a probiotic, or a combination thereof. In some embodiments, the composition can be a fecal transplant. The fecal transplant can be administered in a therapeutically effective amount to increase the amount of gastrointestinal microbiota when consumed by the subject. The methods described herein can further include administering a therapeutic agent in combination with the composition that modulates the gut microbiota. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110292585-A |
| priorityDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 396.